Akebia Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA), a biopharmaceutical company focused on kidney disease, announced that CEO John P. Butler will present at the 20th Annual Needham Virtual Healthcare Conference on April 15, 2021, at 1:30 p.m. ET. A live webcast of the presentation will be available on the company's Investors page, with a replay accessible for 30 days post-conference. Founded in 2007 and headquartered in Cambridge, Massachusetts, Akebia aims to improve the lives of those affected by kidney disease.

News Market Reaction – AKBA

-2.61%

-2.61% Session move

In the trading session that priced this news, AKBA declined 2.61%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., April 12, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer of Akebia, will present at the 20^th Annual Needham Virtual Healthcare Conference on Thursday, April 15 at 1:30 p.m. ET.

A live webcast of the presentation can be accessed through the Investors section of the Company's website at https://ir.akebia.com. A replay of the webcast will be available for approximately 30 days following the conference.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Kristen K. Sheppard, Esq.
ir@akebia.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-20th-annual-needham-virtual-healthcare-conference-301266301.html

SOURCE Akebia Therapeutics, Inc.

FAQ

When will Akebia Therapeutics present at the Needham Virtual Healthcare Conference?

Akebia Therapeutics will present on April 15, 2021, at 1:30 p.m. ET.

Who is the CEO of Akebia Therapeutics?

The CEO of Akebia Therapeutics is John P. Butler.

Where can I watch the Akebia Therapeutics presentation?

The presentation can be accessed through the Investors section of the Akebia website.

How long will the Akebia Therapeutics webcast be available?

The webcast replay will be available for approximately 30 days following the conference.

What is the main focus of Akebia Therapeutics?

Akebia Therapeutics focuses on developing therapeutics for people living with kidney disease.